About
Neuronal stem-cell therapies
Areas of Focus
Categories
Stem Cell & Cellular TherapyBiotech
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
68
By Phase
PHASE1/PHASE2: 2
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
Today
Hover over trial bars to see details
Recent Trials
NCT06422923Lead Sponsor
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
PHASE1/PHASE2Recruiting
10 participants
Started: Nov 14, 2024 · Completed: Jun 15, 2042
NCT05135091Lead Sponsor
FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy
PHASE1/PHASE2Recruiting
58 participants
Started: Jun 16, 2022 · Completed: Feb 28, 2042
Locations (1)
Headquarters
South SF, CA, United States
Map
Loading map...